Defendant: Abbott Labs., Corp et al
Court: C.D. Cal.
Date: Nov 27, 2018
FlexStent, LLC has sued Abbott Laboratories, Corp; Abbot Vascular, Inc.; Abbot Cardiovascular Systems, Inc.; and Abbot Vascular Solutions, Inc. in the Central District of California for infringement of U.S. Patent No. 6,187,035 (“Vascular stent”). FlexStent accuses Abbott’s “Xience” line of drug-eluting stents of infringement.